About 100 Mg Paclitaxel Injection IP
Unveiling the imposing 100 Mg Paclitaxel Injection IP, a scarce asset in cancer care, offering ace therapeutic value against ovarian, breast, and non-small cell lung cancer. Crafted to comply with Indian Pharmacopoeia standards, this sterile, preservative-free solution is presented in a Type I glass vial, ensuring integrity and lowest price without compromise. Redoubtable in cytotoxic efficacy, it demands expert handling and rigorous dilution protocols. Compatible with 0.9% sodium chloride or 5% dextrose, its single 16.7 ml vial is a testament to precision and unfaltering pharmaceutical quality for hospital and clinical use.
Use and Application Features
100 Mg Paclitaxel Injection IP is tailored for intravenous infusion only, used primarily in hospital or clinical environments for targeted cancer therapy. Its ready-to-use formulation requires dilution prior to administration and employs non-PVC sets to ensure safety. This product combines sterile manufacturing standards, precise dosage strength, and compatibility with standard IV fluids, making it a redoubtable option for oncological treatment protocols.
Sample, Payment, and Shipment Policy
Sample requests for 100 Mg Paclitaxel Injection IP are welcomed at the asking price. Once the order is placed, samples are shipped promptly as per agreed payment terms. The shipment policy prioritizes quick and secure delivery, ensuring your sample arrives safely. All transactions respect established trading protocols, making procurement convenient and reliable for distributors, exporters, suppliers, and traders across India.
FAQ's of 100 Mg Paclitaxel Injection IP:
Q: How should 100 Mg Paclitaxel Injection IP be administered?
A: 100 Mg Paclitaxel Injection IP must only be administered as an intravenous infusion. The solution requires dilution with 0.9% sodium chloride or 5% dextrose before infusion and should be used in a clinical setting by trained professionals.
Q: What precautions are necessary during its usage?
A: Strict cytotoxic handling procedures must be followed, including protective equipment and the use of non-PVC infusion sets and containers to prevent leaching of plasticizers. Only trained personnel should handle and administer this medication.
Q: What types of cancer does it treat?
A: Paclitaxel Injection IP is indicated for the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer, providing a valuable option within established chemotherapy protocols.
Q: Where can I obtain samples and how are they shipped?
A: Samples of 100 Mg Paclitaxel Injection IP can be requested from authorized distributors, suppliers, and exporters in India. Upon payment, shipments are dispatched promptly following secure trading and delivery policies.
Q: What is the shelf life and storage requirement for this product?
A: The injection must be stored below 25C, protected from light, and not frozen. It maintains efficacy for two years from the manufacturing date, ensuring prolonged value and reliability.
Q: Why is dilution required prior to administration?
A: Dilution ensures safe and effective delivery during intravenous infusion and helps achieve the recommended concentration. It is a necessary step for proper pharmacological action and patient safety.